Class information for:
Level 1: PD L1//PD 1//IPILIMUMAB

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
10 4 IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY 1369268
17 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 124793
335 2             CTLA 4//PD L1//PD 1 18269
255 1                   PD L1//PD 1//IPILIMUMAB 3851

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 PD L1 authKW 2746721 13% 68% 492
2 PD 1 authKW 2290683 13% 57% 487
3 IPILIMUMAB authKW 1600959 8% 61% 319
4 NIVOLUMAB authKW 1539573 7% 72% 261
5 PEMBROLIZUMAB authKW 1037041 4% 75% 170
6 IMMUNE CHECKPOINT INHIBITORS authKW 589043 3% 57% 127
7 IMMUNE CHECKPOINT authKW 537052 3% 53% 125
8 PROGRAMMED DEATH 1 authKW 485942 3% 60% 99
9 CHECKPOINT INHIBITORS authKW 468554 3% 51% 112
10 ANTI PD 1 authKW 406785 2% 73% 68

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 39998 53% 0% 2031
2 Immunology 10449 26% 0% 992
3 Medicine, Research & Experimental 2088 10% 0% 377
4 Cell Biology 446 8% 0% 291
5 Pathology 383 3% 0% 133
6 Hematology 357 4% 0% 144
7 Dermatology 304 3% 0% 102
8 Respiratory System 288 3% 0% 111
9 Biotechnology & Applied Microbiology 60 3% 0% 126
10 Rheumatology 56 1% 0% 39

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 LUDWIG CANC IMMUNOTHER Y 186627 1% 45% 51
2 MED ONCOL IMMUNOTHER Y 55412 1% 28% 24
3 DONALD A ADAM COMPREHENS MELANOMA 47134 0% 52% 11
4 IMMUNOONCOL 44425 1% 23% 24
5 MED ONCOL 39391 13% 1% 492
6 IMMUNOMONITORING ONCOL 36443 0% 64% 7
7 MELANOMA DIS 35689 0% 36% 12
8 UMS 3655 32729 0% 100% 4
9 MELANOMA IMMUNOTHER EUT SERV 30115 0% 41% 9
10 IST TOSCANO TUMORI 29252 1% 11% 33

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANCER IMMUNOLOGY RESEARCH 154226 3% 19% 98
2 ONCOIMMUNOLOGY 65735 3% 8% 97
3 IMMUNOTHERAPY 26267 1% 6% 50
4 JOURNAL OF IMMUNOTHERAPY 12383 1% 3% 51
5 CLINICAL CANCER RESEARCH 10151 4% 1% 139
6 ONCOTARGET 7914 3% 1% 127
7 LANCET ONCOLOGY 6615 1% 2% 40
8 JAMA ONCOLOGY 6415 0% 5% 16
9 MELANOMA RESEARCH 6076 1% 2% 37
10 CANCER IMMUNOLOGY IMMUNOTHERAPY 5689 1% 1% 56

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 PD L1 2746721 13% 68% 492 Search PD+L1 Search PD+L1
2 PD 1 2290683 13% 57% 487 Search PD+1 Search PD+1
3 IPILIMUMAB 1600959 8% 61% 319 Search IPILIMUMAB Search IPILIMUMAB
4 NIVOLUMAB 1539573 7% 72% 261 Search NIVOLUMAB Search NIVOLUMAB
5 PEMBROLIZUMAB 1037041 4% 75% 170 Search PEMBROLIZUMAB Search PEMBROLIZUMAB
6 IMMUNE CHECKPOINT INHIBITORS 589043 3% 57% 127 Search IMMUNE+CHECKPOINT+INHIBITORS Search IMMUNE+CHECKPOINT+INHIBITORS
7 IMMUNE CHECKPOINT 537052 3% 53% 125 Search IMMUNE+CHECKPOINT Search IMMUNE+CHECKPOINT
8 PROGRAMMED DEATH 1 485942 3% 60% 99 Search PROGRAMMED+DEATH+1 Search PROGRAMMED+DEATH+1
9 CHECKPOINT INHIBITORS 468554 3% 51% 112 Search CHECKPOINT+INHIBITORS Search CHECKPOINT+INHIBITORS
10 ANTI PD 1 406785 2% 73% 68 Search ANTI+PD+1 Search ANTI+PD+1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 36129 LAG 3//LYMPHOCYTE ACTIVATION GENE 3//CD223
2 22643 B7 H4//B7 H3//SOLUBLE B7 H4
3 8742 TUMOR INFILTRATING LYMPHOCYTES//TERTIARY LYMPHOID STRUCTURES//FOXP3
4 9976 CTLA 4//CTLA 4 GENE//CYTOTOXIC T LYMPHOCYTE ANTIGEN 4
5 19238 IMMUNOGENIC CELL DEATH//U1015//U805
6 11302 TUMOR IMMUNOL BIOL//SIPULEUCEL T//PROSTVAC
7 24712 ICOS//B7RP 1//INDUCIBLE COSTIMULATOR
8 16009 TIM 3//GALECTIN 9//TIM 1
9 1305 VEMURAFENIB//BRAF INHIBITOR//BRAF
10 2712 CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//SURG BRANCH

Go to start page